Showing results (11-20 of 85) with videos related to

Sort By:
Pageof 9
Annals of Palliative Medicine|March 23, 2021
Management of nonbacterial thrombotic endocarditis (NBTE) in advanced non-small cell lung cancer (NSCLC) patients with driver mutation: two case reportsZhanhong Xie, Ran Zhong, Xinqing Lin, et al.
Translational Lung Cancer Research|April 11, 2024
Efficacy and safety of first-line PD-L1/PD-1 inhibitors in limited-stage small cell lung cancer: a multicenter propensity score matched retrospective studyJingyuan Xie, Ke Xu, Zijing Cai, et al.
Chinese Medical Journal|October 15, 2024
Cancer therapy-related interstitial lung diseaseChengzhi Zhou, Haiyi Deng, Yilin Yang, et al.
Cancer Biology & Therapy|June 5, 2019
Unexpected favorable outcome to etoposide and cisplatin in a small cell lung cancer transformed patient: a case reportZhanhong Xie, Yingying Gu, Xinqing Lin, et al.
Immunopharmacology and Immunotoxicology|June 20, 2023
A case report and literature review on respiratory failure with immune checkpoint inhibitors: a life-threatening adverse eventXinqing Lin, Wenhui Guan, Bingliang Li, et al.
Frontiers in Immunology|June 21, 2021
Case Report: A Rare Case of Metachronous Multiple Primary Lung Cancers in a Patient With Successful Management by Switching From Anti-PD-1 Therapy to Anti-PD-L1 TherapyXinqing Lin, Guihuan Qiu, Fang Li, et al.
Frontiers in Oncology|September 27, 2024
Pulmonary alveolar proteinosis complicated by lung cancer with favorable prognosis: a case report and literature reviewYing Wu, Wenhui Guan, Jiaxi Deng, et al.
Clinical Lung Cancer|August 2, 2024
Evaluating Safety and Clinical Activity of Front-line Treatment with Cadonilimab plus Chemotherapy in Advanced/Metastatic Nonsmall Cell Lung Cancer Harboring STK11 Genetic Aberration: A Protocol of Phase II StudyHuixin Jiang, Ni Sun, Ru Li, et al.
Molecular Imaging and Biology|November 24, 2021
Clinical Utility of F-18 Labeled Fibroblast Activation Protein Inhibitor (FAPI) for Primary Staging in Lung Adenocarcinoma: a Prospective StudyYoucai Li, Xinqing Lin, Yi Li, et al.
Thoracic Cancer|April 2, 2023
Clinical impact of first-line PD-1 or PD-L1 inhibitors combined with chemotherapy in extensive-stage small cell lung cancer patients: A real-world multicenter propensity score-matched studyJingyuan Xie, Mo Chen, Hedong Han, et al.
Pageof 9